IL101945A - Methods for determining an analyte using induced luminescence, and kits therefor - Google Patents

Methods for determining an analyte using induced luminescence, and kits therefor

Info

Publication number
IL101945A
IL101945A IL101945A IL10194592A IL101945A IL 101945 A IL101945 A IL 101945A IL 101945 A IL101945 A IL 101945A IL 10194592 A IL10194592 A IL 10194592A IL 101945 A IL101945 A IL 101945A
Authority
IL
Israel
Prior art keywords
analyte
photosensitizer
pacc
assay
medium
Prior art date
Application number
IL101945A
Other languages
English (en)
Other versions
IL101945A0 (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/704,569 external-priority patent/US6251581B1/en
Priority claimed from US07/718,490 external-priority patent/US5340716A/en
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Priority to IL11630092A priority Critical patent/IL116300A/xx
Publication of IL101945A0 publication Critical patent/IL101945A0/xx
Publication of IL101945A publication Critical patent/IL101945A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Nanotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
IL101945A 1991-05-22 1992-05-21 Methods for determining an analyte using induced luminescence, and kits therefor IL101945A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL11630092A IL116300A (en) 1991-05-22 1992-05-21 Assay methods utilizing induced luminescence

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/704,569 US6251581B1 (en) 1991-05-22 1991-05-22 Assay method utilizing induced luminescence
US07/718,490 US5340716A (en) 1991-06-20 1991-06-20 Assay method utilizing photoactivated chemiluminescent label

Publications (2)

Publication Number Publication Date
IL101945A0 IL101945A0 (en) 1992-12-30
IL101945A true IL101945A (en) 1998-02-08

Family

ID=27107346

Family Applications (1)

Application Number Title Priority Date Filing Date
IL101945A IL101945A (en) 1991-05-22 1992-05-21 Methods for determining an analyte using induced luminescence, and kits therefor

Country Status (10)

Country Link
EP (4) EP1418430A3 (fr)
JP (1) JP3892912B2 (fr)
AT (3) ATE350665T1 (fr)
AU (1) AU657134B2 (fr)
CA (1) CA2069145C (fr)
DE (3) DE69232161T2 (fr)
DK (1) DK0984282T3 (fr)
ES (3) ES2204050T3 (fr)
IL (1) IL101945A (fr)
PT (1) PT984282E (fr)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578498A (en) 1991-05-22 1996-11-26 Behringwerke Ag Metal chelate containing compositions for use in chemiluminescent assays
US6251581B1 (en) 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
CA2141451C (fr) * 1992-07-31 2003-10-07 John S. Pease Matrices chimioluminescentes pouvant etre photoactivees
WO1995006877A1 (fr) * 1993-09-03 1995-03-09 Behringwerke Ag Immunotitrages a formation de canaux d'oxygene fluorescent
US5783453A (en) * 1995-06-29 1998-07-21 Chiron Diagnostics Corporation Non-separation specific binding chemiluminescent assay
EP0793970A1 (fr) * 1996-03-08 1997-09-10 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Inactivation photodynamique de virus
DE69736382T2 (de) * 1996-05-01 2007-08-09 Dade Behring Marburg Gmbh Chemilumineszente zusammensetungen und ihre verwendung zum nachweis von wasserstoffperoxid
DE19756782A1 (de) 1997-12-19 1999-06-24 Dade Behring Marburg Gmbh Nachweis und Bestimmung festphasenassoziierter Faktoren
DE19756773A1 (de) 1997-12-19 1999-06-24 Dade Behring Marburg Gmbh Neues Verfahren und Diagnosemittel zur Hämostase-Diagnostik
US6365346B1 (en) 1998-02-18 2002-04-02 Dade Behring Inc. Quantitative determination of nucleic acid amplification products
JP2002504689A (ja) 1998-02-18 2002-02-12 デイド・ベーリング・インコーポレイテッド 複数の検体の検出において使用するための化学ルミネセンス組成物
DE19811017A1 (de) 1998-03-13 1999-09-16 Dade Behring Marburg Gmbh Neues Verfahren zur Bestimmung von Plasmaproteinen und Faktoren der Hämostase sowie ein neues, implantierbares Meßgerät
US6303325B1 (en) 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
AUPP405098A0 (en) * 1998-06-12 1998-07-02 Access Pharmaceuticals Australia Pty Limited Novel methods of preparation of vitamin b12 derivatives suitable for conjugation to pharmaceuticals
US6703248B1 (en) * 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
ATE395364T1 (de) 1999-12-22 2008-05-15 Dade Behring Marburg Gmbh Gegen procalcitonin gerichtete antikörper, ihre herstellung und verwendung
DE50014159D1 (de) 1999-12-22 2007-04-26 Dade Behring Marburg Gmbh Lösungen von humanem Procalcitonin
KR20030011777A (ko) * 2000-02-28 2003-02-11 다이이치 가가쿠 야쿠힝 가부시키가이샤 장수명 여기형 형광을 이용하는 측정방법
US7179660B1 (en) 2000-03-06 2007-02-20 Dade Behring Marburg Gmbh Carriers coated with polysaccharides, their preparation and use
US6346384B1 (en) * 2000-03-27 2002-02-12 Dade Behring Inc. Real-time monitoring of PCR using LOCI
EP1305632B1 (fr) * 2000-05-04 2011-07-27 Siemens Healthcare Diagnostics Products GmbH Methodes servant a la detection d'analytes multiples
DE10064827A1 (de) 2000-12-22 2002-06-27 Dade Behring Marburg Gmbh Nachweisverfahren
JP2004535371A (ja) * 2001-03-16 2004-11-25 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション 蛍光コバラミンおよびその使用
US7524974B2 (en) 2002-07-08 2009-04-28 Tetsuo Nagano Fluorescent probe
US6764819B2 (en) * 2002-07-16 2004-07-20 Emp Biotech Gmbh Method for chemiluminescent detection
US7696245B2 (en) 2003-03-28 2010-04-13 Sekisui Medical Co., Ltd. Fluorescent probe for zinc
WO2005062048A1 (fr) 2003-12-01 2005-07-07 Dade Behring Marburg Gmbh Procede de detection homogene
JP2005194244A (ja) 2004-01-09 2005-07-21 Shigenobu Yano 亜鉛イオン蛍光センサー
DE102005026163A1 (de) 2004-08-24 2006-03-02 Dade Behring Marburg Gmbh Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung
DE102004042124B4 (de) * 2004-08-30 2006-07-06 Dade Behring Marburg Gmbh Homogenes Verfahren zur Bestimmung eines Analyten in Gegenwart eines Überschusses von kreuzreagierenden Substanzen
JP2008513794A (ja) * 2004-09-17 2008-05-01 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド 三価金属媒介均一発光近接アッセイ
US20060166376A1 (en) 2005-01-21 2006-07-27 Craig Alan R Compositions for use as a signal generation component and methods of using same
US7682839B2 (en) * 2005-03-14 2010-03-23 Lumigen, Inc. Methods using novel chemiluminescent labels
IL168184A (en) * 2005-04-21 2011-11-30 Univ Ariel Res & Dev Co Ltd Use of a ligand-photosensitizer conjugate in combination with a chemiluminescent agent in the manufacture of a medicament for photodynamic therapy
DE102005022047A1 (de) 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
GB0520436D0 (en) 2005-10-07 2005-11-16 Photobiotics Ltd Biological materials and uses thereof
US7732153B2 (en) * 2006-05-09 2010-06-08 Beckman Coulter, Inc. Nonseparation assay methods
US20080213797A1 (en) * 2007-03-01 2008-09-04 Abbott Laboratories Immunoassays exhibiting a reduction in prozone phenomena
DE102007017906A1 (de) 2007-04-17 2008-10-23 Dade Behring Marburg Gmbh Verfahren zur Bestimmung der Reaktions-Lag-Phase in einer analytabhängigen Reaktion
US7790401B2 (en) * 2007-08-06 2010-09-07 Siemens Healthcare Diagnostics Methods for detection of immunosuppressant drugs
US11730407B2 (en) 2008-03-28 2023-08-22 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8583204B2 (en) 2008-03-28 2013-11-12 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8682408B2 (en) 2008-03-28 2014-03-25 Dexcom, Inc. Polymer membranes for continuous analyte sensors
DE102008049601A1 (de) 2008-09-30 2010-04-01 Siemens Healthcare Diagnostics Products Gmbh Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay
EP2177624A1 (fr) * 2008-10-02 2010-04-21 Siemens Healthcare Diagnostics Products GmbH Analyses de coagulation sanguine
JP5419775B2 (ja) * 2010-03-30 2014-02-19 日本電信電話株式会社 測定用基板、並びに、これを用いた生化学的結合形成および生化学的結合量の測定方法
EP2395354A1 (fr) 2010-06-10 2011-12-14 Siemens Healthcare Diagnostics Products GmbH Test d'activité homogène destiné à la détermination de réactions enzymatiques
EP2471945A1 (fr) 2010-12-30 2012-07-04 Siemens Healthcare Diagnostics Products GmbH Procédé de détermination d'inhibiteurs de coagulation
RU2473885C2 (ru) * 2011-02-02 2013-01-27 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный университет" Количественный анализ тиомочевины и флуоресцеина натрия при их совместном присутствии в пластовых водах
DE102011007546A1 (de) * 2011-04-15 2012-10-18 Humboldt-Universität Zu Berlin Messvorrichtung für eine Messung einer Singulettsauerstoff-Lumineszenz
WO2013044099A1 (fr) 2011-09-23 2013-03-28 Siemens Healthcare Diagnostics Inc. Dosage de sensibilité cellulaire pour un cancer et procédés de production et d'utilisation associés
EP2708892B1 (fr) 2012-09-18 2015-04-15 Siemens Healthcare Diagnostics Products GmbH Méthode pour la détermination d'analytes associés aux thrombocytes
DE102012220083B3 (de) * 2012-11-05 2014-03-06 Technische Universität Dresden Verfahren und System zum direkten, strahlungslosen Energietransfer über flüssige Phasengrenzen
DK2972245T3 (da) 2013-03-15 2020-09-07 Siemens Healthcare Diagnostics Inc Heterogene luminescerende oxygenkanaliserende immunoassays
EP2790019A1 (fr) 2013-04-10 2014-10-15 Siemens Healthcare Diagnostics Products GmbH Détection d'effet crochet à haute dose
US10124072B2 (en) 2013-09-18 2018-11-13 Caliper Life Sciences, Inc. In-vivo reactive species imaging
GB201319180D0 (en) * 2013-10-30 2013-12-11 Mast Group Ltd Nucleic acid probe
ES2614352T3 (es) 2014-03-11 2017-05-30 Siemens Healthcare Diagnostics Products Gmbh Método para la detección de moduladores de la interacción de GPIb-trombina
JP6596440B2 (ja) * 2014-03-26 2019-10-23 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッド ３つの抗体を利用する発光酸素チャネリング免疫測定法並びにその製造方法及び使用
EP2955517A1 (fr) 2014-06-10 2015-12-16 Siemens Healthcare Diagnostics Products GmbH Procédé de stabilisation d'échantillons de liquide corporel par administration de détergent
WO2018106945A1 (fr) * 2016-12-07 2018-06-14 Progenity Inc. Procédés, dispositifs et systèmes de détection du tractus gastro-intestinal
ES2826394T3 (es) 2017-06-09 2021-05-18 Siemens Healthcare Diagnostics Products Gmbh Ensayo de activación para el diagnóstico de una trombocitopenia inducida por heparina
EP3438667B1 (fr) 2017-08-02 2020-12-30 Siemens Healthcare Diagnostics Products GmbH Essai de liaison pour diagnostiquer la thrombocytopénie induite par l'héparine
WO2019043553A1 (fr) * 2017-08-31 2019-03-07 3M Innovative Properties Company Identification de motifs périodiques lisibles par machine
EP3514541A1 (fr) 2018-01-17 2019-07-24 Siemens Healthcare Diagnostics Products GmbH Procédé de détermination quantitative d'un inhibiteur du tnf-alpha thérapeutique
CN108676555B (zh) * 2018-05-28 2020-11-20 青岛农业大学 一种含铕离子液体红光材料及制备方法和应用
CN116577319A (zh) * 2018-07-18 2023-08-11 上海索昕生物科技有限公司 一种用于化学发光检测的微球组合物及其应用
CN116593713A (zh) * 2019-07-19 2023-08-15 科美博阳诊断技术(上海)有限公司 一种供体试剂在诊断主体心肌损伤中的用途
CN113125705B (zh) * 2019-12-31 2023-08-04 科美诊断技术(苏州)有限公司 一种肌红蛋白的均相检测试剂盒及其应用
JP7116819B2 (ja) * 2020-03-19 2022-08-10 財團法人工業技術研究院 １級アミド化合物の検出試薬、検出装置、および検出方法
CN111795960B (zh) * 2020-08-10 2022-08-09 齐齐哈尔大学 一种光谱法和比色法检测不同形式碘的分子平台及其制备方法和应用
CN117241884A (zh) * 2021-04-21 2023-12-15 美国西门子医学诊断股份有限公司 使用抗人免疫球蛋白抗体用于抗微生物血清学测定的组合物、试剂盒和方法
WO2022235065A1 (fr) * 2021-05-07 2022-11-10 Seegene, Inc. Procédé et système pour détermination de concentration de billes magnétiques en suspension
EP4239338A1 (fr) 2022-03-03 2023-09-06 Siemens Healthcare Diagnostics Products GmbH Essai général destiné à la détermination de l'état du système de coagulation sanguine
EP4325224A1 (fr) 2022-08-18 2024-02-21 Siemens Healthcare Diagnostics Products GmbH Essai d'activation plaquettaire destiné au diagnostic d'une thrombocytopénie induite à l'héparine
CN116429752B (zh) * 2023-02-13 2024-07-19 科美博阳诊断技术(上海)有限公司 Afp检测试剂盒及其使用方法
EP4585926A1 (fr) 2024-01-09 2025-07-16 Siemens Healthcare Diagnostics Products GmbH Procédé et kit pour réduire les interférences dans des dosages immunologiques

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3720622A (en) * 1970-01-02 1973-03-13 American Cyanamid Co Generation of light from the decomposition of dioxetaneones in the presence of a fluorescer
AU517292B2 (en) * 1978-06-20 1981-07-23 Syva Co. Fluorescence quenching system
CA1190838A (fr) * 1981-07-17 1985-07-23 Cavit Akin Procede de diagnostic d'hybridation
CA1273552A (fr) * 1985-12-23 1990-09-04 Michael J. Heller Sondes fluorescentes a decalage de stoke pour les determinations d'hybridation des polynucleotides
US5004565A (en) * 1986-07-17 1991-04-02 The Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US5616729A (en) * 1986-07-17 1997-04-01 Board Of Governors Of Wayne State University Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers
US4959182A (en) * 1986-07-17 1990-09-25 Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US4891324A (en) * 1987-01-07 1990-01-02 Syntex (U.S.A.) Inc. Particle with luminescer for assays
US4881191A (en) * 1987-01-13 1989-11-14 Hewlett-Packard Company Multichannel decimation/interpolation filter
WO1989012232A1 (fr) * 1988-06-08 1989-12-14 London Diagnostics, Inc. Analyses mettant en oeuvre la production de signaux detectables induite par activateur
CA2035029C (fr) * 1989-09-06 2001-12-18 Applied Biosystems, Llc Synthese de 1,2-dioxoethanes hydrosolubles stables et chimiluminescents, et leurs intermediaires
WO1991005605A1 (fr) 1989-10-10 1991-05-02 Kosak Kenneth M Marqueurs en cyclodextrine pour essais immunitaires et analyses biochimiques
DE69125992T2 (de) * 1990-09-14 1997-08-21 Tosoh Corp Verfahren und Kit für Immunoassay

Also Published As

Publication number Publication date
EP0984282B1 (fr) 2003-07-30
ATE246360T1 (de) 2003-08-15
EP1418430A3 (fr) 2004-09-01
AU657134B2 (en) 1995-03-02
JPH05180773A (ja) 1993-07-23
ES2204050T3 (es) 2004-04-16
EP0984281A3 (fr) 2000-06-07
EP1418430A2 (fr) 2004-05-12
PT984282E (pt) 2003-12-31
JP3892912B2 (ja) 2007-03-14
EP0984282A3 (fr) 2000-06-07
DE69233674T2 (de) 2007-10-18
DE69232161D1 (de) 2001-12-06
DK0984282T3 (da) 2003-11-17
ATE350665T1 (de) 2007-01-15
CA2069145C (fr) 2007-07-31
EP0984281B1 (fr) 2007-01-03
ES2168092T3 (es) 2002-06-01
DE69233146T2 (de) 2004-04-29
IL101945A0 (en) 1992-12-30
ES2280110T3 (es) 2007-09-01
CA2069145A1 (fr) 1992-11-23
DE69233674D1 (de) 2007-02-15
EP0515194A3 (en) 1993-10-20
ATE208039T1 (de) 2001-11-15
EP0984281A2 (fr) 2000-03-08
AU1706892A (en) 1992-11-26
DE69233146D1 (de) 2003-09-04
EP0515194B1 (fr) 2001-10-31
EP0515194A2 (fr) 1992-11-25
EP0984282A2 (fr) 2000-03-08
DE69232161T2 (de) 2002-05-16

Similar Documents

Publication Publication Date Title
EP0984282B1 (fr) Particules contenant une composition comprenant un composé chimioluminescent
US6251581B1 (en) Assay method utilizing induced luminescence
US5709994A (en) Photoactivatable chemiluminescent matrices
US5340716A (en) Assay method utilizing photoactivated chemiluminescent label
US6406667B1 (en) Chemiluminescent compositions for use in detection of multiple analytes
EP0730738B1 (fr) Compositions contenant en chelate d'un metal destinees a etre utilisees dans des determinations par chimioluminescence
US5545834A (en) Chemiluminescent compounds and methods of use
US5807675A (en) Fluorescent oxygen channeling immunoassays
US6002000A (en) Chemiluminescent compounds and methods of use
CA2425483C (fr) Methode de dosage faisant appel a la luminescence induite

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired